Moreover, as we have also seen in our study, the overwhelming majority of cells isolated from FSHD patients express no detectible DUX4 or DUX4 target genes, raising the question of what the anti-DUX4 therapies are actually targeting. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.